Guardant Health Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Guardant Health are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 19, 2019 and ending today September 17, 2019. Click here to learn more.
USD 5.04  6.96%

Guardant Health Summary

Guardant Health (GH) is traded on BATS Exchange in USA. It is located in 505 Penobscot Drive and employs 454 people. Guardant Health is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with market capitalization of 8.05B. Guardant Health is active under Healthcare sector as part of Diagnostics & Research industry. The entity has 92.97M outstanding shares of which 2.45M shares are currently sold short in the market by investors with about 2.44 days to cover all shorted shares. The company reports about 545.63M in cash with (66.72M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.87.
Check Guardant Health Probability Of Bankruptcy

Ownership Allocation (%)

Guardant Health Target Price Odds Analysis

Odds Below 77.5HorizonTargetOdds Above 77.5
5.52%30 days 77.50 94.44%
Based on normal probability distribution, the odds of Guardant Health to move above current price in 30 days from now is under 95% (This Guardant Health probability density function shows the probability of Guardant Health Stock to fall within a particular range of prices over 30 days) .

Guardant Health Top Holders

Guardant Health Risk Profiles

Guardant Health Key Fundamentals

Guardant Health Against Markets

Guardant Health Vital Trading Data

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 454 people. more
Fama & French Healthcare
Fama & French Classification
Guardant Health SEC Filings
Guardant Health SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameGuardant Health
CEO, DirectorHelmy EltoukhyView All
Thematic Classification
Currently Active Investing Idea
View All
Macroaxis Advice
Healthcare, Diagnostics & Research
InstrumentUSA Stock View All
LocationCalifornia U.S.A
Business Address505 Penobscot Drive
ExchangeBATS Exchange
IndustryDiagnostics & Research
Phone855 698 8887
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestAugust 15, 2019

Guardant Health Corporate Directors

Dipchand Nishar Independent Director
Ian Clark Lead Independent Director
Bahija Jallal Director
Please also check Risk vs Return Analysis. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.